Peptilogics, Inc. Patent Application Trends in 2024: Difference between revisions
Updating Peptilogics, Inc._Patent_Application_Trends_in_2024 |
Updating Peptilogics, Inc._Patent_Application_Trends_in_2024 |
||
| Line 5: | Line 5: | ||
[[File:Peptilogics, Inc. Top Technology Areas 2024 - Up to June 2024.png|border|800px|Peptilogics, Inc. Top Technology Areas 2024 - Up to June 2024]] | [[File:Peptilogics, Inc. Top Technology Areas 2024 - Up to June 2024.png|border|800px|Peptilogics, Inc. Top Technology Areas 2024 - Up to June 2024]] | ||
* [[:Category:CPC_A61K38/10|A61K38/10]] ( | * [[:Category:CPC_A61K38/10|A61K38/10]] (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms) | ||
** Count: 1 patents | ** Count: 1 patents | ||
** Example: [[20240115654. INTRAVENOUS ADMINISTRATION OF ENGINEERED ANTIMICROBIAL AMPHIPHILIC PEPTIDES simplified abstract (Peptilogics, Inc.)]] | ** Example: [[20240115654. INTRAVENOUS ADMINISTRATION OF ENGINEERED ANTIMICROBIAL AMPHIPHILIC PEPTIDES simplified abstract (Peptilogics, Inc.)]] | ||
* [[:Category:CPC_A61K9/0019|A61K9/0019]] ( | * [[:Category:CPC_A61K9/0019|A61K9/0019]] (Medicinal preparations characterised by special physical form {(nuclear magnetic resonance contrast preparations or magnetic resonance imaging contrast preparations) | ||
** Count: 1 patents | ** Count: 1 patents | ||
** Example: [[20240115654. INTRAVENOUS ADMINISTRATION OF ENGINEERED ANTIMICROBIAL AMPHIPHILIC PEPTIDES simplified abstract (Peptilogics, Inc.)]] | ** Example: [[20240115654. INTRAVENOUS ADMINISTRATION OF ENGINEERED ANTIMICROBIAL AMPHIPHILIC PEPTIDES simplified abstract (Peptilogics, Inc.)]] | ||
* [[:Category:CPC_A61P31/04|A61P31/04]] ( | * [[:Category:CPC_A61P31/04|A61P31/04]] (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS) | ||
** Count: 1 patents | ** Count: 1 patents | ||
** Example: [[20240115654. INTRAVENOUS ADMINISTRATION OF ENGINEERED ANTIMICROBIAL AMPHIPHILIC PEPTIDES simplified abstract (Peptilogics, Inc.)]] | ** Example: [[20240115654. INTRAVENOUS ADMINISTRATION OF ENGINEERED ANTIMICROBIAL AMPHIPHILIC PEPTIDES simplified abstract (Peptilogics, Inc.)]] | ||
* [[:Category:CPC_A61P31/12|A61P31/12]] ( | * [[:Category:CPC_A61P31/12|A61P31/12]] (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS) | ||
** Count: 1 patents | ** Count: 1 patents | ||
** Example: [[20240115654. INTRAVENOUS ADMINISTRATION OF ENGINEERED ANTIMICROBIAL AMPHIPHILIC PEPTIDES simplified abstract (Peptilogics, Inc.)]] | ** Example: [[20240115654. INTRAVENOUS ADMINISTRATION OF ENGINEERED ANTIMICROBIAL AMPHIPHILIC PEPTIDES simplified abstract (Peptilogics, Inc.)]] | ||
* [[:Category:CPC_C07K1/042|C07K1/042]] ( | * [[:Category:CPC_C07K1/042|C07K1/042]] (on carriers {() | ||
** Count: 1 patents | ** Count: 1 patents | ||
** Example: [[20240002431. METHODS OF MAKING AND USING PLATFORMS FOR PEPTIDE SYNTHESIS AND COMPOSITIONS THEREOF simplified abstract (Peptilogics, Inc.)]] | ** Example: [[20240002431. METHODS OF MAKING AND USING PLATFORMS FOR PEPTIDE SYNTHESIS AND COMPOSITIONS THEREOF simplified abstract (Peptilogics, Inc.)]] | ||
* [[:Category:CPC_B01J19/0046|B01J19/0046]] ( | * [[:Category:CPC_B01J19/0046|B01J19/0046]] ({Sequential or parallel reactions, e.g. for the synthesis of polypeptides or polynucleotides; Apparatus and devices for combinatorial chemistry or for making molecular arrays (synthesis methods per se) | ||
** Count: 1 patents | ** Count: 1 patents | ||
** Example: [[20240002431. METHODS OF MAKING AND USING PLATFORMS FOR PEPTIDE SYNTHESIS AND COMPOSITIONS THEREOF simplified abstract (Peptilogics, Inc.)]] | ** Example: [[20240002431. METHODS OF MAKING AND USING PLATFORMS FOR PEPTIDE SYNTHESIS AND COMPOSITIONS THEREOF simplified abstract (Peptilogics, Inc.)]] | ||
* [[:Category:CPC_C07K1/045|C07K1/045]] ( | * [[:Category:CPC_C07K1/045|C07K1/045]] ({using devices to improve synthesis, e.g. reactors, special vessels}) | ||
** Count: 1 patents | ** Count: 1 patents | ||
** Example: [[20240002431. METHODS OF MAKING AND USING PLATFORMS FOR PEPTIDE SYNTHESIS AND COMPOSITIONS THEREOF simplified abstract (Peptilogics, Inc.)]] | ** Example: [[20240002431. METHODS OF MAKING AND USING PLATFORMS FOR PEPTIDE SYNTHESIS AND COMPOSITIONS THEREOF simplified abstract (Peptilogics, Inc.)]] | ||
* [[:Category:CPC_B01J2219/00648|B01J2219/00648]] ( | * [[:Category:CPC_B01J2219/00648|B01J2219/00648]] (CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS) | ||
** Count: 1 patents | ** Count: 1 patents | ||
** Example: [[20240002431. METHODS OF MAKING AND USING PLATFORMS FOR PEPTIDE SYNTHESIS AND COMPOSITIONS THEREOF simplified abstract (Peptilogics, Inc.)]] | ** Example: [[20240002431. METHODS OF MAKING AND USING PLATFORMS FOR PEPTIDE SYNTHESIS AND COMPOSITIONS THEREOF simplified abstract (Peptilogics, Inc.)]] | ||
* [[:Category:CPC_B01J2219/00725|B01J2219/00725]] ( | * [[:Category:CPC_B01J2219/00725|B01J2219/00725]] (CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS) | ||
** Count: 1 patents | ** Count: 1 patents | ||
** Example: [[20240002431. METHODS OF MAKING AND USING PLATFORMS FOR PEPTIDE SYNTHESIS AND COMPOSITIONS THEREOF simplified abstract (Peptilogics, Inc.)]] | ** Example: [[20240002431. METHODS OF MAKING AND USING PLATFORMS FOR PEPTIDE SYNTHESIS AND COMPOSITIONS THEREOF simplified abstract (Peptilogics, Inc.)]] | ||
* [[:Category:CPC_G16B40/00|G16B40/00]] ( | * [[:Category:CPC_G16B40/00|G16B40/00]] (ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding) | ||
** Count: 1 patents | ** Count: 1 patents | ||
** Example: [[20240203529. GENERATING ENHANCED GRAPHICAL USER INTERFACES FOR PRESENTATION OF ANTI-INFECTIVE DESIGN SPACES FOR SELECTING DRUG CANDIDATES simplified abstract (Peptilogics, Inc.)]] | ** Example: [[20240203529. GENERATING ENHANCED GRAPHICAL USER INTERFACES FOR PRESENTATION OF ANTI-INFECTIVE DESIGN SPACES FOR SELECTING DRUG CANDIDATES simplified abstract (Peptilogics, Inc.)]] | ||
| Line 38: | Line 38: | ||
[[File:Peptilogics, Inc. Top Emerging Technology Areas 2024 - Up to June 2024.png|border|800px|Peptilogics, Inc. Top Emerging Technology Areas 2024 - Up to June 2024]] | [[File:Peptilogics, Inc. Top Emerging Technology Areas 2024 - Up to June 2024.png|border|800px|Peptilogics, Inc. Top Emerging Technology Areas 2024 - Up to June 2024]] | ||
* [[:Category:CPC_G16H40/20|G16H40/20]] ( | * [[:Category:CPC_G16H40/20|G16H40/20]] (for the management or administration of healthcare resources or facilities, e.g. managing hospital staff or surgery rooms) | ||
** Count: 1 patents | ** Count: 1 patents | ||
** Example: [[20240203529. GENERATING ENHANCED GRAPHICAL USER INTERFACES FOR PRESENTATION OF ANTI-INFECTIVE DESIGN SPACES FOR SELECTING DRUG CANDIDATES simplified abstract (Peptilogics, Inc.)]] | ** Example: [[20240203529. GENERATING ENHANCED GRAPHICAL USER INTERFACES FOR PRESENTATION OF ANTI-INFECTIVE DESIGN SPACES FOR SELECTING DRUG CANDIDATES simplified abstract (Peptilogics, Inc.)]] | ||
* [[:Category:CPC_G06Q50/184|G06Q50/184]] ( | * [[:Category:CPC_G06Q50/184|G06Q50/184]] ({Intellectual property management}) | ||
** Count: 1 patents | ** Count: 1 patents | ||
** Example: [[20240203529. GENERATING ENHANCED GRAPHICAL USER INTERFACES FOR PRESENTATION OF ANTI-INFECTIVE DESIGN SPACES FOR SELECTING DRUG CANDIDATES simplified abstract (Peptilogics, Inc.)]] | ** Example: [[20240203529. GENERATING ENHANCED GRAPHICAL USER INTERFACES FOR PRESENTATION OF ANTI-INFECTIVE DESIGN SPACES FOR SELECTING DRUG CANDIDATES simplified abstract (Peptilogics, Inc.)]] | ||
* [[:Category:CPC_G06Q50/04|G06Q50/04]] ( | * [[:Category:CPC_G06Q50/04|G06Q50/04]] (Manufacturing) | ||
** Count: 1 patents | ** Count: 1 patents | ||
** Example: [[20240203529. GENERATING ENHANCED GRAPHICAL USER INTERFACES FOR PRESENTATION OF ANTI-INFECTIVE DESIGN SPACES FOR SELECTING DRUG CANDIDATES simplified abstract (Peptilogics, Inc.)]] | ** Example: [[20240203529. GENERATING ENHANCED GRAPHICAL USER INTERFACES FOR PRESENTATION OF ANTI-INFECTIVE DESIGN SPACES FOR SELECTING DRUG CANDIDATES simplified abstract (Peptilogics, Inc.)]] | ||
* [[:Category:CPC_G06Q30/0201|G06Q30/0201]] ( | * [[:Category:CPC_G06Q30/0201|G06Q30/0201]] (Market modelling; Market analysis; Collecting market data) | ||
** Count: 1 patents | ** Count: 1 patents | ||
** Example: [[20240203529. GENERATING ENHANCED GRAPHICAL USER INTERFACES FOR PRESENTATION OF ANTI-INFECTIVE DESIGN SPACES FOR SELECTING DRUG CANDIDATES simplified abstract (Peptilogics, Inc.)]] | ** Example: [[20240203529. GENERATING ENHANCED GRAPHICAL USER INTERFACES FOR PRESENTATION OF ANTI-INFECTIVE DESIGN SPACES FOR SELECTING DRUG CANDIDATES simplified abstract (Peptilogics, Inc.)]] | ||
* [[:Category:CPC_G16H70/40|G16H70/40]] ( | * [[:Category:CPC_G16H70/40|G16H70/40]] (relating to drugs, e.g. their side effects or intended usage) | ||
** Count: 1 patents | ** Count: 1 patents | ||
** Example: [[20240203529. GENERATING ENHANCED GRAPHICAL USER INTERFACES FOR PRESENTATION OF ANTI-INFECTIVE DESIGN SPACES FOR SELECTING DRUG CANDIDATES simplified abstract (Peptilogics, Inc.)]] | ** Example: [[20240203529. GENERATING ENHANCED GRAPHICAL USER INTERFACES FOR PRESENTATION OF ANTI-INFECTIVE DESIGN SPACES FOR SELECTING DRUG CANDIDATES simplified abstract (Peptilogics, Inc.)]] | ||
* [[:Category:CPC_G16H50/70|G16H50/70]] ( | * [[:Category:CPC_G16H50/70|G16H50/70]] (for mining of medical data, e.g. analysing previous cases of other patients) | ||
** Count: 1 patents | ** Count: 1 patents | ||
** Example: [[20240203529. GENERATING ENHANCED GRAPHICAL USER INTERFACES FOR PRESENTATION OF ANTI-INFECTIVE DESIGN SPACES FOR SELECTING DRUG CANDIDATES simplified abstract (Peptilogics, Inc.)]] | ** Example: [[20240203529. GENERATING ENHANCED GRAPHICAL USER INTERFACES FOR PRESENTATION OF ANTI-INFECTIVE DESIGN SPACES FOR SELECTING DRUG CANDIDATES simplified abstract (Peptilogics, Inc.)]] | ||
* [[:Category:CPC_G16H50/20|G16H50/20]] ( | * [[:Category:CPC_G16H50/20|G16H50/20]] (for computer-aided diagnosis, e.g. based on medical expert systems) | ||
** Count: 1 patents | ** Count: 1 patents | ||
** Example: [[20240203529. GENERATING ENHANCED GRAPHICAL USER INTERFACES FOR PRESENTATION OF ANTI-INFECTIVE DESIGN SPACES FOR SELECTING DRUG CANDIDATES simplified abstract (Peptilogics, Inc.)]] | ** Example: [[20240203529. GENERATING ENHANCED GRAPHICAL USER INTERFACES FOR PRESENTATION OF ANTI-INFECTIVE DESIGN SPACES FOR SELECTING DRUG CANDIDATES simplified abstract (Peptilogics, Inc.)]] | ||
* [[:Category:CPC_G16H10/20|G16H10/20]] ( | * [[:Category:CPC_G16H10/20|G16H10/20]] (for electronic clinical trials or questionnaires) | ||
** Count: 1 patents | ** Count: 1 patents | ||
** Example: [[20240203529. GENERATING ENHANCED GRAPHICAL USER INTERFACES FOR PRESENTATION OF ANTI-INFECTIVE DESIGN SPACES FOR SELECTING DRUG CANDIDATES simplified abstract (Peptilogics, Inc.)]] | ** Example: [[20240203529. GENERATING ENHANCED GRAPHICAL USER INTERFACES FOR PRESENTATION OF ANTI-INFECTIVE DESIGN SPACES FOR SELECTING DRUG CANDIDATES simplified abstract (Peptilogics, Inc.)]] | ||
* [[:Category:CPC_G16C20/70|G16C20/70]] ( | * [[:Category:CPC_G16C20/70|G16C20/70]] (Machine learning, data mining or chemometrics) | ||
** Count: 1 patents | ** Count: 1 patents | ||
** Example: [[20240203529. GENERATING ENHANCED GRAPHICAL USER INTERFACES FOR PRESENTATION OF ANTI-INFECTIVE DESIGN SPACES FOR SELECTING DRUG CANDIDATES simplified abstract (Peptilogics, Inc.)]] | ** Example: [[20240203529. GENERATING ENHANCED GRAPHICAL USER INTERFACES FOR PRESENTATION OF ANTI-INFECTIVE DESIGN SPACES FOR SELECTING DRUG CANDIDATES simplified abstract (Peptilogics, Inc.)]] | ||
* [[:Category:CPC_G16B45/00|G16B45/00]] ( | * [[:Category:CPC_G16B45/00|G16B45/00]] (ICT specially adapted for bioinformatics-related data visualisation, e.g. displaying of maps or networks) | ||
** Count: 1 patents | ** Count: 1 patents | ||
** Example: [[20240203529. GENERATING ENHANCED GRAPHICAL USER INTERFACES FOR PRESENTATION OF ANTI-INFECTIVE DESIGN SPACES FOR SELECTING DRUG CANDIDATES simplified abstract (Peptilogics, Inc.)]] | ** Example: [[20240203529. GENERATING ENHANCED GRAPHICAL USER INTERFACES FOR PRESENTATION OF ANTI-INFECTIVE DESIGN SPACES FOR SELECTING DRUG CANDIDATES simplified abstract (Peptilogics, Inc.)]] | ||
Latest revision as of 06:44, 20 July 2024
Peptilogics, Inc. Patent Filing Activity
Peptilogics, Inc. patent applications in 2024
Top 10 Technology Areas
- A61K38/10 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms)
- A61K9/0019 (Medicinal preparations characterised by special physical form {(nuclear magnetic resonance contrast preparations or magnetic resonance imaging contrast preparations)
- A61P31/04 (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS)
- A61P31/12 (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS)
- C07K1/042 (on carriers {()
- B01J19/0046 ({Sequential or parallel reactions, e.g. for the synthesis of polypeptides or polynucleotides; Apparatus and devices for combinatorial chemistry or for making molecular arrays (synthesis methods per se)
- C07K1/045 ({using devices to improve synthesis, e.g. reactors, special vessels})
- B01J2219/00648 (CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS)
- B01J2219/00725 (CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS)
- G16B40/00 (ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding)
Emerging Technology Areas
- G16H40/20 (for the management or administration of healthcare resources or facilities, e.g. managing hospital staff or surgery rooms)
- G06Q50/184 ({Intellectual property management})
- G06Q50/04 (Manufacturing)
- G06Q30/0201 (Market modelling; Market analysis; Collecting market data)
- G16H70/40 (relating to drugs, e.g. their side effects or intended usage)
- G16H50/70 (for mining of medical data, e.g. analysing previous cases of other patients)
- G16H50/20 (for computer-aided diagnosis, e.g. based on medical expert systems)
- G16H10/20 (for electronic clinical trials or questionnaires)
- G16C20/70 (Machine learning, data mining or chemometrics)
- G16B45/00 (ICT specially adapted for bioinformatics-related data visualisation, e.g. displaying of maps or networks)
Top Inventors
Error creating thumbnail: File missing
- Jonathan D. STECKBECK of Pittsburgh PA (US) (1 patent)
- David HUANG of Pittsburgh PA (US) (1 patent)
- Despina X. DOBBINS of Pittsburgh PA (US) (1 patent)
- Francis Lee of Pittsburgh PA (US) (1 patent)
- Francis Lee of Cambridge MA (US) (1 patent)
- Jonathan D. Steckbeck of Cranberry Township PA (US) (1 patent)
- Hannes Holste of Los Angeles CA (US) (1 patent)
Patent Categories
Error creating thumbnail: File missing
Geographical Distribution of Inventors
Geographical Distribution of US Inventors
Categories:
- Peptilogics, Inc.
- Companies
- CPC A61K38/10
- CPC A61K9/0019
- CPC A61P31/04
- CPC A61P31/12
- CPC C07K1/042
- CPC B01J19/0046
- CPC C07K1/045
- CPC B01J2219/00648
- CPC B01J2219/00725
- CPC G16B40/00
- CPC G06F3/14
- CPC G06F9/451
- CPC G06F16/2428
- CPC G06F16/248
- CPC G06F16/29
- CPC G06N20/00
- CPC G16B5/00
- CPC G16B10/00
- CPC G16B30/00
- CPC G16B35/00
- CPC G16B45/00
- CPC G16C20/70
- CPC G16H10/20
- CPC G16H50/20
- CPC G16H50/70
- CPC G16H70/40
- CPC G06Q30/0201
- CPC G06Q50/04
- CPC G06Q50/184
- CPC G16H40/20
- Patent Trends by Company in 2024
(Ad) Transform your business with AI in minutes, not months
✓
Custom AI strategy tailored to your specific industry needs
✓
Step-by-step implementation with measurable ROI
✓
5-minute setup that requires zero technical skills
Trusted by 1,000+ companies worldwide
